Deferasirox recalls

The FDA has published 1 recall involving Deferasirox since 2023. The latest was reported on 15 Nov 2023. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2023

Last 12 months0reported

Class I00% of total

Ongoing1latest 15 Nov 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why deferasirox is recalled

Potency & Assay1100%

Companies

Glenmark Pharmaceuticals Inc., USA1100%

By year

20231100%

Ongoing deferasirox recalls

1 active

Reported	Class	Recall	Company	Reason	Where
15 Nov 2023Drug	CLASS II	Deferasirox Tablets for Oral Suspension, 500mg recalledDeferasirox	Glenmark Pharmaceuticals Inc., USA	Potency & Assay	Nationwide

All deferasirox recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
15 Nov 2023Drug	CLASS II	Deferasirox Tablets for Oral Suspension, 500mg recalledDeferasirox	Glenmark Pharmaceuticals Inc., USA	Potency & Assay	Nationwide

Should you stop taking Deferasirox?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.